ÖZKAN, E. Et Al. 2016. Early Response to Everolimus Therapy Detected on Ga-68-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor. CLINICAL NUCLEAR MEDICINE , vol.41, no.7 , 561-563.

ÖZKAN, E., SOYDAL, Ç., Semirgin, S. U., Yapici, O., ATMACA, A., & Demirag, G., (2016). Early Response to Everolimus Therapy Detected on Ga-68-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor. CLINICAL NUCLEAR MEDICINE , vol.41, no.7, 561-563.

ÖZKAN, ELGİN Et Al. "Early Response to Everolimus Therapy Detected on Ga-68-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor," CLINICAL NUCLEAR MEDICINE , vol.41, no.7, 561-563, 2016

ÖZKAN, ELGİN Et Al. "Early Response to Everolimus Therapy Detected on Ga-68-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor." CLINICAL NUCLEAR MEDICINE , vol.41, no.7, pp.561-563, 2016

ÖZKAN, E. Et Al. (2016) . "Early Response to Everolimus Therapy Detected on Ga-68-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor." CLINICAL NUCLEAR MEDICINE , vol.41, no.7, pp.561-563.

@article{article, author={ELGİN ÖZKAN Et Al. }, title={Early Response to Everolimus Therapy Detected on Ga-68-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor}, journal={CLINICAL NUCLEAR MEDICINE}, year=2016, pages={561-563} }